Läs mer
Irinotecan hydrochloride trihydrate, 99%, Thermo Scientific™
Topoisomerase I inhibitor
2125.43 SEK - 4184.10 SEK
Kemiska identifierare
| CAS | 136572-09-3 |
|---|---|
| Molekylformel | C33H39ClN4O6 |
| Molekylvikt (g/mol) | 623.15 |
| MDL-nummer | MFCD01862255 |
| InChI-nyckel | GURKHSYORGJETM-WAQYZQTGSA-N |
| Synonym | irinotecan hydrochloride, irinotecan hcl, topotecin, campto, cpt-11, cpt 11, camptothecin 11 hydrochloride, camptothecin 11, unii-06x131e4oe |
| PubChem CID | 74990 |
| ChEBI | CHEBI:5971 |
| IUPAC-namn | hydrogen (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate chloride |
| LEDER | [H+].[Cl-].CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O |
| Produktkod | Brand | Kvantitet | Pris | Kvantitet och tillgänglighet | |||||
|---|---|---|---|---|---|---|---|---|---|
| Produktkod | Brand | Kvantitet | Pris | Kvantitet och tillgänglighet | |||||
|
15424769
|
Thermo Scientific Alfa Aesar
J62370.MC |
100mg |
2125.43 SEK
100mg |
Vänligen Logga in för att beställa denna produkten. Behöver du ett Webbkonto? Registrera ditt konto idag! | |||||
|
15434769
|
Thermo Scientific Alfa Aesar
J62370.MD |
250mg |
4184.10 SEK
250mg |
Vänligen Logga in för att beställa denna produkten. Behöver du ett Webbkonto? Registrera ditt konto idag! | |||||
Description
This Thermo Scientific brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific.
Chemical Identifiers
| 136572-09-3 | |
| 623.15 | |
| GURKHSYORGJETM-WAQYZQTGSA-N | |
| 74990 | |
| hydrogen (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate chloride |
| C33H39ClN4O6 | |
| MFCD01862255 | |
| irinotecan hydrochloride, irinotecan hcl, topotecin, campto, cpt-11, cpt 11, camptothecin 11 hydrochloride, camptothecin 11, unii-06x131e4oe | |
| CHEBI:5971 | |
| [H+].[Cl-].CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O |
Specifications
| Irinotecan hydrochloride trihydrate | |
| C33H39ClN4O6 | |
| 14,5091 | |
| Soluble in DMSO at 100mg/ml; Soluble in water at 25mg/ml with warming | |
| [H+].[Cl-].CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O | |
| 623.15 | |
| CHEBI:5971 | |
| 99% |
| 136572-09-3 | |
| MFCD01862255 | |
| irinotecan hydrochloride, irinotecan hcl, topotecin, campto, cpt-11, cpt 11, camptothecin 11 hydrochloride, camptothecin 11, unii-06x131e4oe | |
| GURKHSYORGJETM-WAQYZQTGSA-N | |
| hydrogen (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate chloride | |
| 74990 | |
| 677.19 (623.15 Anhydrous) |
Safety and Handling
GHS H Statement
H302
Harmful if swallowed.
P264b-P270-P301+P312-P330-P501c
H302
missing translation for 'rtecsNumber' : DW1060750
missing translation for 'tsca' : No
Recommended Storage : Keep cold
- Irinotecan hydrochloride trihydrate
Signal Word
- Fara
Hazard Category
- Akut toxicitet Kategorija 4
- Specifik organtoxicitet - upprepad exponering Kategorija 1
Hazard Statement
- H302-Skadligt vid förtäring.
- H372-Orsakar organskador.
Precautionary Statement
- P260-Inandas inte damm/rök/gaser/dimma/ångor/ sprej.
- P264-Tvätta grundligt efter användning.
- P301+P330+P331-VID FÖRTÄRING: Skölj munnen. Framkalla INTE kräkning.
- P312-Vid obehag, kontakta GIFTINFORMATIONSCENTRALEN/läkare/ .
Supplemental information
- MIXTURE LIST-Contain: Irinotecan hydrochloride trihydrate
RUO – Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.